Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
iNAP Lab+ icon

1.3.6 by Chang Chun Chien


May 24, 2024

About iNAP Lab+

User could collect information of oximeter and therapy device.

Before you use this App, the compatible devices are below. iNAP One device has received regulatory clearance or license in the USA, EU, Taiwan, Thailand, Hong Kong, Malaysia, Singapore, and Australia. The first compatible Oximeter (Model: TD-8255) has received regulatory clearance or license in the USA, EU, Taiwan, and Japan. The second compatible Oximeter (Model: PC-68B) has received regulatory clearance in the USA. If you are NOT in these countries, you need to confirm the availability when you use these devices and this App based on local regulations in your country.

Disclaimer

· Blood Oxygen Monitoring - Blood oxygen monitoring should not be used as a medical device to diagnose disease.

· Blood Oxygen Monitoring - Blood oxygen monitoring is not intended for medical emergencies. If you need any help, please consult your primary care physician.

· Blood oxygen monitoring is for general health/fitness use only

What's New in the Latest Version 1.3.6

Last updated on May 24, 2024

1. Fix the remote pressure setting bug.
2. Upgrade target SDK to Android 14.

Translation Loading...

Additional APP Information

Latest Version

Request iNAP Lab+ Update 1.3.6

Uploaded by

Andreas KC

Requires Android

Android 7.0+

Available on

Get iNAP Lab+ on Google Play

Show More

iNAP Lab+ Screenshots

Comment Loading...
Languages
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.